Aptose Biosciences Inc.
APS.TO
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.15M | 7.96M | 8.33M | 9.33M | 9.25M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.25M | 912.00K | 1.24M | 1.82M | 2.04M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.13M | 1.36M | 593.00K | 674.00K | 600.00K |
| Total Current Assets | 9.53M | 10.24M | 10.16M | 11.82M | 11.89M |
|
|
|||||
| Total Current Assets | 9.53M | 10.24M | 10.16M | 11.82M | 11.89M |
| Net Property, Plant & Equipment | 597.00K | 694.00K | 790.00K | 975.00K | 1.10M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00 | -- | -- | -- | 0.00 |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 10.13M | 10.93M | 10.95M | 12.80M | 12.99M |
|
|
|||||
| Total Accounts Payable | 1.26M | 1.83M | 7.11M | 2.42M | 6.05M |
| Total Accrued Expenses | 2.77M | 7.51M | 5.20M | 9.32M | 8.83M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 428.00K | 416.00K | 404.00K | 399.00K | 394.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 4.46M | 9.76M | 12.71M | 12.14M | 15.27M |
|
|
|||||
| Total Current Liabilities | 4.46M | 9.76M | 12.71M | 12.14M | 15.27M |
| Long-Term Debt | 10.02M | 10.00M | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 193.00K | 305.00K | 414.00K | 520.00K | 621.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 14.67M | 20.06M | 13.13M | 12.66M | 15.89M |
|
|
|||||
| Common Stock & APIC | 540.74M | 534.56M | 534.57M | 529.63M | 516.95M |
| Retained Earnings | -540.97M | -539.38M | -532.43M | -525.18M | -515.54M |
| Treasury Stock & Other | -4.32M | -4.32M | -4.32M | -4.32M | -4.32M |
| Total Common Equity | -4.54M | -9.13M | -2.18M | 137.00K | -2.90M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -4.54M | -9.13M | -2.18M | 137.00K | -2.90M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -4.54M | -9.13M | -2.18M | 137.00K | -2.90M |
|
|
|||||